Timothy Schmid - 02 Sep 2026 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Reporting relationship: EVP, WW Chair, MedTech
Issuer ticker: JNJ
Reported as of: 02 Sep 2026
Net transaction value: -$9,230,440
SEC form: 4
Accepted by SEC: 04 Sep 2026, 09:08:07 UTC
Prior SEC filing: 23 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Joleen Morgan, as attorney-in-fact for Timothy Schmid

Key filing fact

Timothy Schmid filed Form 4 for JOHNSON & JOHNSON (JNJ) on 04 Sep 2026.

Key facts

This page summarizes Timothy Schmid's Form 4 filing for JOHNSON & JOHNSON (JNJ).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 04 Sep 2026, 09:08.

Change

Previous filing in this sequence was filed on 23 Feb 2026.
Current net transaction value: -$9,230,440.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001998491 Primary reporting owner

Schmid Timothy

Relationship: EVP, WW Chair, MedTech
Address: ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK
Signature: /s/ Joleen Morgan, as attorney-in-fact for Timothy Schmid
Signature date: 04 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

JNJ transaction

Common Stock

Options Exercise

Transaction value
Shares: +11,070
Change %: +44%
Price: $131.94^*
Shares after: 36,517
Date: 02 Sep 2026
Ownership: Direct

JNJ transaction

Common Stock

Sale

Transaction value: $3,041,372
Shares: -11,070
Change %: -30%
Price: $274.74
Shares after: 25,447
Date: 02 Sep 2026
Ownership: Direct

JNJ transaction

Common Stock

Options Exercise

Transaction value
Shares: +22,527
Change %: +89%
Price: $151.41^*
Shares after: 47,974
Date: 02 Sep 2026
Ownership: Direct

JNJ transaction

Common Stock

Sale

Transaction value: $6,189,068
Shares: -22,527
Change %: -47%
Price: $274.74
Shares after: 25,447
Date: 02 Sep 2026
Ownership: Direct

JNJ holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 758
Date: 02 Sep 2026
Ownership: By 401k
Footnotes: F1

JNJ holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 46
Date: 02 Sep 2026
Ownership: By ESOP
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

JNJ transaction Derivative

Employee Stock Options (Right to Buy)

Options Exercise

Transaction value
Shares: -11,070
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 02 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 11,070
Exercise price: $131.94
Footnotes: F3

JNJ transaction Derivative

Employee Stock Options (Right to Buy)

Options Exercise

Transaction value
Shares: -22,527
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 02 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 22,527
Exercise price: $151.41
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (8/31/2026).

Footnote F2

Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (8/31/2026).

Footnote F3

Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.